Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 14,516,000 | 11,427,000 | 10,277,000 | 9,864,000 | 10,083,000 |
| Cost of Goods | 4,157,000 | 2,711,000 | 2,007,000 | 1,826,000 | 1,940,000 |
| Gross Profit | 10,359,000 | 8,716,000 | 8,270,000 | 8,038,000 | 8,143,000 |
| Operating Expenses | 5,670,000 | 8,013,000 | 5,822,000 | 5,966,000 | 5,116,000 |
| Operating Income | 4,689,000 | 703,000 | 2,448,000 | 2,072,000 | 3,027,000 |
| Other Income | 1,003,000 | -105,000 | -1,878,000 | 954,000 | -185,000 |
| Pre-tax Income | 5,692,000 | 598,000 | 570,000 | 3,026,000 | 2,842,000 |
| Income Tax | 808,000 | -64,000 | -347,000 | 422,000 | 359,000 |
| Net Income Continuous | 4,885,000 | 662,000 | 917,000 | 2,604,000 | 2,483,000 |
| Net Income Discontinuous | 1,000 | 195,000 | 560,000 | 893,000 | 881,000 |
| Minority Interests | 9,000 | 11,000 | 8,000 | 8,000 | 9,000 |
| Net Income | $4,877,000 | $846,000 | $1,469,000 | $3,489,000 | $3,355,000 |
| EPS Basic Total Ops | 0.87 | 0.16 | 0.26 | 0.63 | 0.60 |
| EPS Basic Continuous Ops | 0.87 | 0.11 | 0.16 | 0.47 | 0.45 |
| EPS Basic Discontinuous Ops | 0.00 | 0.04 | 0.10 | 0.16 | 0.16 |
| EPS Diluted Total Ops | 0.86 | 0.15 | 0.26 | 0.62 | 0.60 |
| EPS Diluted Continuous Ops | 0.86 | 0.12 | 0.16 | 0.46 | 0.44 |
| EPS Diluted Discontinuous Ops | 0.00 | 0.03 | 0.10 | 0.16 | 0.16 |
| EBITDA(a) | $5,896,000 | $1,811,000 | $3,656,000 | $3,271,000 | $4,193,000 |